Breaking News: Japan Approves Lilly’s Kisunla (Donanemab-AZBT) for Early Symptomatic Alzheimer’s Disease Treatment

Kisunla Receives Approval in Japan for Alzheimer’s Disease Treatment INDIANAPOLIS, Sept. 24, 2024 /PRNewswire/ — The Ministry of Health, Labour and Welfare Japan has approved Kisunla™, Eli Lilly and Company’s Alzheimer’s treatment for adults with early symptomatic Alzheimer’s disease (AD) Kisunla™ (donanemab-azbt) has been granted approval in Japan, marking a significant milestone for Eli Lilly…

Read More

Group Eleven Strikes Gold: Impressive 108.5m of Mineralization Uncovered in Massive 360m StepOut at Ballywire, Including High-Grade 5.6m of 13% ZnPb and 116 g/t Ag

Welcome to the Future of Mining: Group Eleven Resources Corp’s Latest Discoveries The Latest Breakthrough in Mining Technology Vancouver, British Columbia–(Newsfile Corp. – September 24, 2024) – Group Eleven Resources Corp. (TSXV: ZNG) (OTC Pink: GRLVF) (FSE: 3GE) (“Group Eleven” or the “Company”) is thrilled to reveal the results from the five most recent step-out…

Read More

Join the Fun: Don’t Miss Out on the Webtoon Entertainment Class Action Lawsuit! Deadline Approaching – Act Now or Regret Later! Contact Levi & Korsinsky for the Scoop!

Oh No, Here We Go Again! Class Action Securities Lawsuit in the World of WEBTOON Entertainment Inc. NEW YORK, Sept. 24, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in WEBTOON Entertainment Inc. (“WEBTOON Entertainment Inc.” or the “Company”) (NASDAQ: WBTN) of a class action securities lawsuit. Well, well, well, what do we have…

Read More